-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KgW1Z4cls2C+K06wDdygd2EIQYCkDY3jOV+jL+qEFfqVs5NGTTdYbRB1AGmHADYS 6Odt/M1IFcVlIzysvrTPTg== 0001257957-05-000027.txt : 20050519 0001257957-05-000027.hdr.sgml : 20050519 20050519205843 ACCESSION NUMBER: 0001257957-05-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050518 FILED AS OF DATE: 20050519 DATE AS OF CHANGE: 20050519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FORREST K MICHAEL CENTRAL INDEX KEY: 0001043164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 05846271 BUSINESS ADDRESS: BUSINESS PHONE: 4155241600 MAIL ADDRESS: STREET 1: 1065 E HILLSDALE BLVD STREET 2: STE 418 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-05-18 0 0000873303 AVI BIOPHARMA INC AVII 0001043164 FORREST K MICHAEL 1065 E HILLSDALE BLVD, STE 418 FOSTER CITY CA 94404 1 0 0 0 Non-Qualified Stock Option (right to buy) 2.24 2005-05-18 4 A 0 10000 0 A 2005-06-15 2015-05-18 Common Stock 10000 10000 D Non-Qualified Stock Option (right to buy) 2.64 2006-03-04 2015-03-04 Common Stock 33000 33000 D Option Grant vests monthly until all shares are vested one year from date of grant. Vesting: 25% of the shares vest each year from the date of grant with all shares vesting in four years. By: Mark M. Webber, Attorney-in-fact For: K. Michael Forrest 2005-05-19 -----END PRIVACY-ENHANCED MESSAGE-----